Global Drug of Abuse (DOA) Testing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 170297
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 118
  • list Medical Devices

Drugs of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat.

Scope of the Report:

During the forecast period, the Drug of Abuse (DOA) Testing market is expected to witness the fastest growth in the APAC region.

The worldwide market for Drug of Abuse (DOA) Testing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Drug of Abuse (DOA) Testing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Siemens

Merck

Roche

Thermo Fisher Scientific

Bio-Rad

Abbott

Quest Diagnostics

Express Diagnostics Int'l

Psychemedics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Urine

Saliva

Hair

Others

Market Segment by Applications, can be divided into

Hospitals

Laboratories

Workplace

At-Home

There are 15 Chapters to deeply display the global Drug of Abuse (DOA) Testing market.

Chapter 1, to describe Drug of Abuse (DOA) Testing Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Drug of Abuse (DOA) Testing, with sales, revenue, and price of Drug of Abuse (DOA) Testing, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Drug of Abuse (DOA) Testing, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Drug of Abuse (DOA) Testing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Drug of Abuse (DOA) Testing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Drug of Abuse (DOA) Testing Introduction

1.2 Market Analysis by Type

1.2.1 Urine

1.2.2 Saliva

1.2.3 Hair

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Laboratories

1.3.3 Workplace

1.3.4 At-Home

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Siemens

2.1.1 Business Overview

2.1.2 Drug of Abuse (DOA) Testing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Siemens Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Merck

2.2.1 Business Overview

2.2.2 Drug of Abuse (DOA) Testing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Merck Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Roche

2.3.1 Business Overview

2.3.2 Drug of Abuse (DOA) Testing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Roche Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Thermo Fisher Scientific

2.4.1 Business Overview

2.4.2 Drug of Abuse (DOA) Testing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Bio-Rad

2.5.1 Business Overview

2.5.2 Drug of Abuse (DOA) Testing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Bio-Rad Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Abbott

2.6.1 Business Overview

2.6.2 Drug of Abuse (DOA) Testing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Abbott Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Quest Diagnostics

2.7.1 Business Overview

2.7.2 Drug of Abuse (DOA) Testing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Express Diagnostics Int'l

2.8.1 Business Overview

2.8.2 Drug of Abuse (DOA) Testing Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Psychemedics

2.9.1 Business Overview

2.9.2 Drug of Abuse (DOA) Testing Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Psychemedics Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Drug of Abuse (DOA) Testing Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Drug of Abuse (DOA) Testing Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Drug of Abuse (DOA) Testing Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Drug of Abuse (DOA) Testing Manufacturer Market Share in 2017

3.3.2 Top 6 Drug of Abuse (DOA) Testing Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Drug of Abuse (DOA) Testing Market Analysis by Regions

4.1 Global Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Regions

4.1.1 Global Drug of Abuse (DOA) Testing Sales and Market Share by Regions (2013-2018)

4.1.2 Global Drug of Abuse (DOA) Testing Revenue and Market Share by Regions (2013-2018)

4.2 North America Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

4.3 Europe Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

4.5 South America Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

5 North America Drug of Abuse (DOA) Testing by Countries

5.1 North America Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries

5.1.1 North America Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)

5.1.2 North America Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)

5.2 United States Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

5.3 Canada Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

5.4 Mexico Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

6 Europe Drug of Abuse (DOA) Testing by Countries

6.1 Europe Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries

6.1.1 Europe Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)

6.2 Germany Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

6.3 UK Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

6.4 France Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

6.5 Russia Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

6.6 Italy Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

7 Asia-Pacific Drug of Abuse (DOA) Testing by Countries

7.1 Asia-Pacific Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)

7.2 China Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

7.3 Japan Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

7.4 Korea Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

7.5 India Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

8 South America Drug of Abuse (DOA) Testing by Countries

8.1 South America Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries

8.1.1 South America Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)

8.1.2 South America Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

8.3 Argentina Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

8.4 Colombia Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

9 Middle East and Africa Drug of Abuse (DOA) Testing by Countries

9.1 Middle East and Africa Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

9.3 UAE Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

9.4 Egypt Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

9.5 Nigeria Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

9.6 South Africa Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

10 Global Drug of Abuse (DOA) Testing Market Segment by Type

10.1 Global Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Drug of Abuse (DOA) Testing Sales and Market Share by Type (2013-2018)

10.1.2 Global Drug of Abuse (DOA) Testing Revenue and Market Share by Type (2013-2018)

10.2 Urine Sales Growth and Price

10.2.1 Global Urine Sales Growth (2013-2018)

10.2.2 Global Urine Price (2013-2018)

10.3 Saliva Sales Growth and Price

10.3.1 Global Saliva Sales Growth (2013-2018)

10.3.2 Global Saliva Price (2013-2018)

10.4 Hair Sales Growth and Price

10.4.1 Global Hair Sales Growth (2013-2018)

10.4.2 Global Hair Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Drug of Abuse (DOA) Testing Market Segment by Application

11.1 Global Drug of Abuse (DOA) Testing Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Laboratories Sales Growth (2013-2018)

11.4 Workplace Sales Growth (2013-2018)

11.5 At-Home Sales Growth (2013-2018)

12 Drug of Abuse (DOA) Testing Market Forecast (2018-2023)

12.1 Global Drug of Abuse (DOA) Testing Sales, Revenue and Growth Rate (2018-2023)

12.2 Drug of Abuse (DOA) Testing Market Forecast by Regions (2018-2023)

12.2.1 North America Drug of Abuse (DOA) Testing Market Forecast (2018-2023)

12.2.2 Europe Drug of Abuse (DOA) Testing Market Forecast (2018-2023)

12.2.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Forecast (2018-2023)

12.2.4 South America Drug of Abuse (DOA) Testing Market Forecast (2018-2023)

12.2.5 Middle East and Africa Drug of Abuse (DOA) Testing Market Forecast (2018-2023)

12.3 Drug of Abuse (DOA) Testing Market Forecast by Type (2018-2023)

12.3.1 Global Drug of Abuse (DOA) Testing Sales Forecast by Type (2018-2023)

12.3.2 Global Drug of Abuse (DOA) Testing Market Share Forecast by Type (2018-2023)

12.4 Drug of Abuse (DOA) Testing Market Forecast by Application (2018-2023)

12.4.1 Global Drug of Abuse (DOA) Testing Sales Forecast by Application (2018-2023)

12.4.2 Global Drug of Abuse (DOA) Testing Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Drug of Abuse (DOA) Testing Picture

Table Product Specifications of Drug of Abuse (DOA) Testing

Figure Global Sales Market Share of Drug of Abuse (DOA) Testing by Ty

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery